A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.

NCT01164384 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Chronic HCV Hepatitis C

Interventions

DRUG: Baminercept

Sponsor

University of Zurich

Collaborators

[object Object]